Joanne Barnes

Summary

Affiliation: University of Auckland
Country: New Zealand

Publications

  1. ncbi Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking
    Natalie Walker
    Clinical Trials Research Unit, School of Population Health, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
    BMC Public Health 11:880. 2011
  2. ncbi Consumers of natural health products: natural-born pharmacovigilantes?
    Rishma Walji
    Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada
    BMC Complement Altern Med 10:8. 2010
  3. ncbi A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, London, UK
    Planta Med 72:378-82. 2006
  4. ncbi Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, 29 39 Brunswick Square, London WC1N 1AX, UK
    J Pharm Pharmacol 57:929-54. 2005
  5. ncbi Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected]
    Joel Gagnier
    Department of Health Policy, Management and Evaluation, Department of Medicine, Univerity of Toronto, Toronto, Canada
    Explore (NY) 2:143-9. 2006

Collaborators

Detail Information

Publications5

  1. ncbi Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking
    Natalie Walker
    Clinical Trials Research Unit, School of Population Health, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
    BMC Public Health 11:880. 2011
    ..4% in the cytisine group compared to 2.4% in the placebo group (Relative risk = 3.4, 95% confidence intervals 1.7-7.1). No research has yet been undertaken to determine the effectiveness of cytisine relative to that of NRT...
  2. ncbi Consumers of natural health products: natural-born pharmacovigilantes?
    Rishma Walji
    Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada
    BMC Complement Altern Med 10:8. 2010
    ..This study examined how consumers respond when they believe they have experienced NHP-related adverse drug reactions (ADRs) in order to determine how to improve current safety monitoring strategies...
  3. ncbi A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, London, UK
    Planta Med 72:378-82. 2006
    ..However, it may be premature to rule out a possible effect on the basis of a single, uncontrolled pilot study, and other approaches involving SJW extract may warrant investigation...
  4. ncbi Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt.,Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties
    Joanne Barnes
    Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London, 29 39 Brunswick Square, London WC1N 1AX, UK
    J Pharm Pharmacol 57:929-54. 2005
    ..Safety issues include the possibility of allergic reactions, the use of echinacea by patients with autoimmune diseases and the potential for echinacea preparations to interact with conventional medicines...
  5. ncbi Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected]
    Joel Gagnier
    Department of Health Policy, Management and Evaluation, Department of Medicine, Univerity of Toronto, Toronto, Canada
    Explore (NY) 2:143-9. 2006
    ..Given that herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized controlled trials (RCTs), such RCTs must clearly report the specifics of the intervention...